As of 2025-07-10, the EV/EBITDA ratio of Charmacy Pharmaceutical Co Ltd (2289.HK) is 6.58. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 2289.HK's latest enterprise value is 1,098.16 mil HKD. 2289.HK's TTM EBITDA according to its financial statements is 166.84 mil HKD. Dividing these 2 quantities gives us the above 2289.HK EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 5.6x - 7.9x | 6.8x |
| Forward P/E multiples | 3.0x - 7.0x | 4.8x |
| Fair Price | 1.79 - 10.22 | 6.47 |
| Upside | -74.6% - 44.9% | -8.2% |
| Date | EV/EBITDA |
| 2025-06-12 | 34.31 |
| 2025-06-11 | 34.31 |
| 2025-06-10 | 34.31 |
| 2025-06-09 | 34.31 |
| 2025-06-06 | 34.31 |
| 2025-06-05 | 31.99 |
| 2025-06-04 | 31.99 |
| 2025-06-03 | 35.70 |
| 2025-06-02 | 35.70 |
| 2025-05-30 | 35.70 |
| 2025-05-29 | 35.70 |
| 2025-05-28 | 35.70 |
| 2025-05-27 | 35.70 |
| 2025-05-26 | 35.29 |
| 2025-05-23 | 37.56 |
| 2025-05-22 | 37.56 |
| 2025-05-21 | 37.56 |
| 2025-05-20 | 37.56 |
| 2025-05-19 | 37.79 |
| 2025-05-16 | 37.79 |
| 2025-05-15 | 37.79 |
| 2025-05-14 | 37.79 |
| 2025-05-13 | 37.79 |
| 2025-05-12 | 37.79 |
| 2025-05-09 | 37.79 |
| 2025-05-08 | 37.79 |
| 2025-05-07 | 37.79 |
| 2025-05-06 | 37.79 |
| 2025-05-02 | 37.79 |
| 2025-04-30 | 37.79 |
| 2025-04-29 | 37.79 |
| 2025-04-28 | 37.79 |
| 2025-04-25 | 37.79 |
| 2025-04-24 | 37.79 |
| 2025-04-23 | 37.79 |
| 2025-04-22 | 37.56 |
| 2025-04-17 | 37.33 |
| 2025-04-16 | 37.09 |
| 2025-04-15 | 37.09 |
| 2025-04-14 | 37.09 |
| 2025-04-11 | 37.09 |
| 2025-04-10 | 37.47 |
| 2025-04-09 | 37.09 |
| 2025-04-08 | 37.09 |
| 2025-04-07 | 37.09 |
| 2025-04-03 | 38.02 |
| 2025-04-02 | 38.02 |
| 2025-04-01 | 37.93 |
| 2025-03-31 | 37.93 |
| 2025-03-28 | 37.93 |